Share Price and Basic Stock Data
Last Updated: March 13, 2025, 2:46 pm
| PEG Ratio | 1.72 |
|---|
Competitors of Jubilant Ingrevia Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| GRM Overseas Ltd | 1,632 Cr. | 270 | 289/113 | 32.1 | 60.6 | 0.00 % | 12.9 % | 18.3 % | 2.00 |
| Freshtrop Fruits Ltd | 89.4 Cr. | 112 | 175/105 | 145 | 0.00 % | 6.40 % | 51.6 % | 10.0 | |
| Chamanlal Setia Exports Ltd | 1,553 Cr. | 300 | 447/181 | 15.3 | 131 | 0.75 % | 20.2 % | 17.4 % | 2.00 |
| Mangalam Global Enterprise Ltd | 476 Cr. | 14.4 | 17.0/8.64 | 14.9 | 5.80 | 0.07 % | 13.8 % | 15.2 % | 1.00 |
| LT Foods Ltd | 11,562 Cr. | 333 | 452/160 | 19.4 | 105 | 0.59 % | 21.1 % | 19.3 % | 1.00 |
| Industry Average | 3,472.00 Cr | 271.61 | 40.92 | 114.41 | 0.36% | 12.89% | 17.86% | 3.50 |
Quarterly Result
| Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,286 | 1,296 | 1,166 | 1,304 | 1,158 | 1,145 | 1,075 | 1,020 | 966 | 1,074 | 1,024 | 1,045 | 1,057 |
| Expenses | 1,074 | 1,153 | 1,025 | 1,151 | 1,007 | 1,043 | 958 | 902 | 871 | 983 | 915 | 921 | 918 |
| Operating Profit | 213 | 142 | 141 | 153 | 151 | 102 | 117 | 118 | 96 | 91 | 110 | 124 | 138 |
| OPM % | 17% | 11% | 12% | 12% | 13% | 9% | 11% | 12% | 10% | 8% | 11% | 12% | 13% |
| Other Income | 9 | 9 | 10 | 7 | 7 | 9 | 8 | 9 | 9 | 10 | 10 | 10 | 9 |
| Interest | 5 | 6 | 4 | 5 | 7 | 6 | 11 | 13 | 15 | 14 | 14 | 15 | 12 |
| Depreciation | 30 | 31 | 31 | 31 | 30 | 30 | 32 | 34 | 34 | 36 | 39 | 40 | 40 |
| Profit before tax | 187 | 115 | 116 | 124 | 122 | 76 | 81 | 80 | 55 | 51 | 66 | 80 | 96 |
| Tax % | 31% | 40% | 31% | 32% | 25% | 31% | 29% | 28% | 30% | 43% | 26% | 26% | 27% |
| Net Profit | 129 | 69 | 79 | 84 | 92 | 52 | 58 | 57 | 39 | 29 | 49 | 59 | 69 |
| EPS in Rs | 8.10 | 4.31 | 4.98 | 5.29 | 5.75 | 3.28 | 3.62 | 3.61 | 2.42 | 1.84 | 3.06 | 3.70 | 4.36 |
Last Updated: February 28, 2025, 7:00 pm
Below is a detailed analysis of the quarterly data for Jubilant Ingrevia Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is ₹1,057.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,045.00 Cr. (Sep 2024) to ₹1,057.00 Cr., marking an increase of ₹12.00 Cr..
- For Expenses, as of Dec 2024, the value is ₹918.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 921.00 Cr. (Sep 2024) to ₹918.00 Cr., marking a decrease of 3.00 Cr..
- For Operating Profit, as of Dec 2024, the value is ₹138.00 Cr.. The value appears strong and on an upward trend. It has increased from 124.00 Cr. (Sep 2024) to ₹138.00 Cr., marking an increase of ₹14.00 Cr..
- For OPM %, as of Dec 2024, the value is 13.00%. The value appears strong and on an upward trend. It has increased from 12.00% (Sep 2024) to 13.00%, marking an increase of 1.00%.
- For Other Income, as of Dec 2024, the value is ₹9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 10.00 Cr. (Sep 2024) to ₹9.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Dec 2024, the value is ₹12.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 15.00 Cr. (Sep 2024) to ₹12.00 Cr., marking a decrease of 3.00 Cr..
- For Depreciation, as of Dec 2024, the value is ₹40.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 40.00 Cr..
- For Profit before tax, as of Dec 2024, the value is ₹96.00 Cr.. The value appears strong and on an upward trend. It has increased from 80.00 Cr. (Sep 2024) to ₹96.00 Cr., marking an increase of ₹16.00 Cr..
- For Tax %, as of Dec 2024, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Sep 2024) to 27.00%, marking an increase of 1.00%.
- For Net Profit, as of Dec 2024, the value is ₹69.00 Cr.. The value appears strong and on an upward trend. It has increased from 59.00 Cr. (Sep 2024) to ₹69.00 Cr., marking an increase of ₹10.00 Cr..
- For EPS in Rs, as of Dec 2024, the value is 4.36. The value appears strong and on an upward trend. It has increased from ₹3.70 (Sep 2024) to 4.36, marking an increase of 0.66.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 6, 2025, 3:47 pm
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
|---|---|---|---|---|---|---|
| Sales | 0 | 684 | 4,949 | 4,773 | 4,136 | 4,201 |
| Expenses | 0 | 567 | 4,108 | 4,224 | 3,708 | 3,737 |
| Operating Profit | -0 | 117 | 841 | 549 | 427 | 463 |
| OPM % | 17% | 17% | 11% | 10% | 11% | |
| Other Income | 0 | -10 | 22 | 32 | 29 | 39 |
| Interest | 0 | 7 | 31 | 22 | 53 | 55 |
| Depreciation | 0 | 22 | 123 | 122 | 136 | 154 |
| Profit before tax | -0 | 77 | 709 | 437 | 268 | 293 |
| Tax % | 0% | 30% | 33% | 30% | 32% | |
| Net Profit | -0 | 54 | 477 | 308 | 183 | 206 |
| EPS in Rs | -3.40 | 3.41 | 29.93 | 19.31 | 11.48 | 12.96 |
| Dividend Payout % | 0% | 10% | 17% | 26% | 43% |
YoY Net Profit Growth
| Year | 2021-2022 | 2022-2023 | 2023-2024 |
|---|---|---|---|
| YoY Net Profit Growth (%) | 783.33% | -35.43% | -40.58% |
| Change in YoY Net Profit Growth (%) | 0.00% | -818.76% | -5.15% |
Jubilant Ingrevia Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 3 years from 2021-2022 to 2023-2024.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 82% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 43% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 14% |
| 1 Year: | 58% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 13% |
| Last Year: | 7% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 14, 2024, 9:34 pm
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Equity Capital | 0.05 | 16 | 16 | 16 | 16 | 16 |
| Reserves | -0 | 1,907 | 2,417 | 2,650 | 2,722 | 2,800 |
| Borrowings | 0 | 556 | 238 | 407 | 740 | 720 |
| Other Liabilities | 0 | 888 | 1,111 | 1,176 | 1,241 | 1,306 |
| Total Liabilities | 0 | 3,366 | 3,782 | 4,249 | 4,719 | 4,841 |
| Fixed Assets | 0 | 1,805 | 1,798 | 1,846 | 2,539 | 2,539 |
| CWIP | 0 | 65 | 174 | 525 | 331 | 455 |
| Investments | 0 | 50 | 6 | 8 | 15 | 19 |
| Other Assets | 0 | 1,446 | 1,804 | 1,870 | 1,834 | 1,829 |
| Total Assets | 0 | 3,366 | 3,782 | 4,249 | 4,719 | 4,841 |
Below is a detailed analysis of the balance sheet data for Jubilant Ingrevia Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹16.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹2,800.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹2,722.00 Cr. (Mar 2024) to ₹2,800.00 Cr., marking an increase of 78.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹720.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from ₹740.00 Cr. (Mar 2024) to ₹720.00 Cr., marking a decrease of 20.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹1,306.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹1,241.00 Cr. (Mar 2024) to ₹1,306.00 Cr., marking an increase of 65.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹4,841.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹4,719.00 Cr. (Mar 2024) to ₹4,841.00 Cr., marking an increase of 122.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹2,539.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹2,539.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹455.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹331.00 Cr. (Mar 2024) to ₹455.00 Cr., marking an increase of 124.00 Cr..
- For Investments, as of Sep 2024, the value is ₹19.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹15.00 Cr. (Mar 2024) to ₹19.00 Cr., marking an increase of 4.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹1,829.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹1,834.00 Cr. (Mar 2024) to ₹1,829.00 Cr., marking a decrease of 5.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹4,841.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹4,719.00 Cr. (Mar 2024) to ₹4,841.00 Cr., marking an increase of 122.00 Cr..
Notably, the Reserves (₹2,800.00 Cr.) exceed the Borrowings (720.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|
| Free Cash Flow | 0.00 | -439.00 | 603.00 | 142.00 | -313.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|
| Debtor Days | 251 | 43 | 39 | 50 | |
| Inventory Days | 601 | 117 | 146 | 160 | |
| Days Payable | 685 | 103 | 113 | 131 | |
| Cash Conversion Cycle | 167 | 57 | 72 | 80 | |
| Working Capital Days | 269 | 59 | 61 | 64 | |
| ROCE % | 8% | 29% | 16% | 10% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| DSP Small Cap Fund | 5,188,657 | 1.84 | 217.82 | 20,406 | 2025-03-11 | 25327.11% |
| DSP Mid Cap Fund | 3,926,722 | 1.14 | 164.84 | 20,406 | 2025-03-11 | 19142.98% |
| Nippon India Small Cap Fund | 1,156,299 | 0.13 | 48.54 | 20,406 | 2025-03-11 | 5566.47% |
| DSP Top 100 Equity Fund | 1,082,115 | 1.54 | 45.43 | 20,406 | 2025-03-11 | 5202.93% |
| DSP Tiger Fund | 877,161 | 1.49 | 36.82 | 20,406 | 2025-03-11 | 4198.54% |
| DSP Equity Savings Fund | 148,777 | 0.91 | 6.25 | 20,406 | 2025-03-11 | 629.08% |
| Nippon India Nifty Smallcap 250 Index Fund | 44,284 | 0.26 | 1.86 | 20,406 | 2025-03-11 | 117.01% |
| Motilal Oswal Nifty Smallcap 250 Index Fund | 27,802 | 0.26 | 1.17 | 20,406 | 2025-03-11 | 36.24% |
| DSP Regular Savings Fund | 22,959 | 0.54 | 0.97 | 20,406 | 2025-03-11 | 12.51% |
| SBI Nifty Smallcap 250 Index Fund | 20,406 | 0.26 | 0.86 | 20,406 | 2025-03-11 | 0% |
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 11.56 | 19.34 | 29.98 | 20.78 | -3.31 |
| Diluted EPS (Rs.) | 11.55 | 19.34 | 29.97 | 20.78 | -3.31 |
| Cash EPS (Rs.) | 20.19 | 27.03 | 37.75 | 4.80 | -3.32 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 173.27 | 167.72 | 153.06 | 120.73 | -2.32 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 173.27 | 167.72 | 153.06 | 120.73 | -2.32 |
| Revenue From Operations / Share (Rs.) | 261.78 | 300.23 | 311.34 | 42.95 | 0.00 |
| PBDIT / Share (Rs.) | 28.89 | 36.52 | 54.31 | 7.52 | -3.32 |
| PBIT / Share (Rs.) | 20.27 | 28.83 | 46.55 | 6.13 | -3.32 |
| PBT / Share (Rs.) | 16.94 | 27.47 | 44.60 | 4.86 | -3.32 |
| Net Profit / Share (Rs.) | 11.57 | 19.35 | 29.99 | 3.41 | -3.32 |
| NP After MI And SOA / Share (Rs.) | 11.58 | 19.34 | 29.99 | 3.41 | -3.32 |
| PBDIT Margin (%) | 11.03 | 12.16 | 17.44 | 17.50 | 0.00 |
| PBIT Margin (%) | 7.74 | 9.60 | 14.95 | 14.27 | 0.00 |
| PBT Margin (%) | 6.47 | 9.15 | 14.32 | 11.31 | 0.00 |
| Net Profit Margin (%) | 4.42 | 6.44 | 9.63 | 7.94 | 0.00 |
| NP After MI And SOA Margin (%) | 4.42 | 6.44 | 9.63 | 7.94 | 0.00 |
| Return on Networth / Equity (%) | 6.68 | 11.53 | 19.59 | 2.82 | 0.00 |
| Return on Capital Employeed (%) | 9.29 | 14.88 | 26.96 | 3.93 | 143.10 |
| Return On Assets (%) | 3.86 | 7.22 | 12.55 | 1.60 | -332.00 |
| Long Term Debt / Equity (X) | 0.15 | 0.05 | 0.04 | 0.23 | 0.00 |
| Total Debt / Equity (X) | 0.26 | 0.14 | 0.09 | 0.23 | 0.00 |
| Asset Turnover Ratio (%) | 0.92 | 1.16 | 1.38 | 0.41 | 0.00 |
| Current Ratio (X) | 1.38 | 1.54 | 1.68 | 1.59 | 0.30 |
| Quick Ratio (X) | 0.65 | 0.66 | 0.81 | 0.91 | 0.30 |
| Inventory Turnover Ratio (X) | 2.06 | 2.84 | 4.08 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 43.18 | 25.84 | 9.52 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 24.75 | 18.49 | 7.56 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 56.82 | 74.16 | 90.48 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 75.25 | 81.51 | 92.44 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 8.67 | 26.90 | 27.91 | 16.34 | 0.00 |
| Interest Coverage Ratio (Post Tax) (X) | 4.47 | 15.25 | 16.41 | 10.18 | 0.00 |
| Enterprise Value (Cr.) | 7789.81 | 6031.88 | 7331.49 | 4498.03 | 0.00 |
| EV / Net Operating Revenue (X) | 1.88 | 1.26 | 1.48 | 6.57 | 0.00 |
| EV / EBITDA (X) | 17.07 | 10.39 | 8.49 | 37.57 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 1.73 | 1.20 | 1.44 | 6.08 | 0.00 |
| Retention Ratios (%) | 56.81 | 74.15 | 90.47 | 0.00 | 0.00 |
| Price / BV (X) | 2.61 | 2.15 | 2.94 | 2.16 | 0.00 |
| Price / Net Operating Revenue (X) | 1.73 | 1.20 | 1.44 | 6.08 | 0.00 |
| EarningsYield | 0.02 | 0.05 | 0.06 | 0.01 | 0.00 |
After reviewing the key financial ratios for Jubilant Ingrevia Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 11.56. This value is within the healthy range. It has decreased from 19.34 (Mar 23) to 11.56, marking a decrease of 7.78.
- For Diluted EPS (Rs.), as of Mar 24, the value is 11.55. This value is within the healthy range. It has decreased from 19.34 (Mar 23) to 11.55, marking a decrease of 7.79.
- For Cash EPS (Rs.), as of Mar 24, the value is 20.19. This value is within the healthy range. It has decreased from 27.03 (Mar 23) to 20.19, marking a decrease of 6.84.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 173.27. It has increased from 167.72 (Mar 23) to 173.27, marking an increase of 5.55.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 173.27. It has increased from 167.72 (Mar 23) to 173.27, marking an increase of 5.55.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 261.78. It has decreased from 300.23 (Mar 23) to 261.78, marking a decrease of 38.45.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 28.89. This value is within the healthy range. It has decreased from 36.52 (Mar 23) to 28.89, marking a decrease of 7.63.
- For PBIT / Share (Rs.), as of Mar 24, the value is 20.27. This value is within the healthy range. It has decreased from 28.83 (Mar 23) to 20.27, marking a decrease of 8.56.
- For PBT / Share (Rs.), as of Mar 24, the value is 16.94. This value is within the healthy range. It has decreased from 27.47 (Mar 23) to 16.94, marking a decrease of 10.53.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 11.57. This value is within the healthy range. It has decreased from 19.35 (Mar 23) to 11.57, marking a decrease of 7.78.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 11.58. This value is within the healthy range. It has decreased from 19.34 (Mar 23) to 11.58, marking a decrease of 7.76.
- For PBDIT Margin (%), as of Mar 24, the value is 11.03. This value is within the healthy range. It has decreased from 12.16 (Mar 23) to 11.03, marking a decrease of 1.13.
- For PBIT Margin (%), as of Mar 24, the value is 7.74. This value is below the healthy minimum of 10. It has decreased from 9.60 (Mar 23) to 7.74, marking a decrease of 1.86.
- For PBT Margin (%), as of Mar 24, the value is 6.47. This value is below the healthy minimum of 10. It has decreased from 9.15 (Mar 23) to 6.47, marking a decrease of 2.68.
- For Net Profit Margin (%), as of Mar 24, the value is 4.42. This value is below the healthy minimum of 5. It has decreased from 6.44 (Mar 23) to 4.42, marking a decrease of 2.02.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 4.42. This value is below the healthy minimum of 8. It has decreased from 6.44 (Mar 23) to 4.42, marking a decrease of 2.02.
- For Return on Networth / Equity (%), as of Mar 24, the value is 6.68. This value is below the healthy minimum of 15. It has decreased from 11.53 (Mar 23) to 6.68, marking a decrease of 4.85.
- For Return on Capital Employeed (%), as of Mar 24, the value is 9.29. This value is below the healthy minimum of 10. It has decreased from 14.88 (Mar 23) to 9.29, marking a decrease of 5.59.
- For Return On Assets (%), as of Mar 24, the value is 3.86. This value is below the healthy minimum of 5. It has decreased from 7.22 (Mar 23) to 3.86, marking a decrease of 3.36.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.15. This value is below the healthy minimum of 0.2. It has increased from 0.05 (Mar 23) to 0.15, marking an increase of 0.10.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.26. This value is within the healthy range. It has increased from 0.14 (Mar 23) to 0.26, marking an increase of 0.12.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.92. It has decreased from 1.16 (Mar 23) to 0.92, marking a decrease of 0.24.
- For Current Ratio (X), as of Mar 24, the value is 1.38. This value is below the healthy minimum of 1.5. It has decreased from 1.54 (Mar 23) to 1.38, marking a decrease of 0.16.
- For Quick Ratio (X), as of Mar 24, the value is 0.65. This value is below the healthy minimum of 1. It has decreased from 0.66 (Mar 23) to 0.65, marking a decrease of 0.01.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.06. This value is below the healthy minimum of 4. It has decreased from 2.84 (Mar 23) to 2.06, marking a decrease of 0.78.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 43.18. This value is within the healthy range. It has increased from 25.84 (Mar 23) to 43.18, marking an increase of 17.34.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 24.75. This value is within the healthy range. It has increased from 18.49 (Mar 23) to 24.75, marking an increase of 6.26.
- For Earning Retention Ratio (%), as of Mar 24, the value is 56.82. This value is within the healthy range. It has decreased from 74.16 (Mar 23) to 56.82, marking a decrease of 17.34.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 75.25. This value exceeds the healthy maximum of 70. It has decreased from 81.51 (Mar 23) to 75.25, marking a decrease of 6.26.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 8.67. This value is within the healthy range. It has decreased from 26.90 (Mar 23) to 8.67, marking a decrease of 18.23.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 4.47. This value is within the healthy range. It has decreased from 15.25 (Mar 23) to 4.47, marking a decrease of 10.78.
- For Enterprise Value (Cr.), as of Mar 24, the value is 7,789.81. It has increased from 6,031.88 (Mar 23) to 7,789.81, marking an increase of 1,757.93.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.88. This value is within the healthy range. It has increased from 1.26 (Mar 23) to 1.88, marking an increase of 0.62.
- For EV / EBITDA (X), as of Mar 24, the value is 17.07. This value exceeds the healthy maximum of 15. It has increased from 10.39 (Mar 23) to 17.07, marking an increase of 6.68.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.73. This value is within the healthy range. It has increased from 1.20 (Mar 23) to 1.73, marking an increase of 0.53.
- For Retention Ratios (%), as of Mar 24, the value is 56.81. This value is within the healthy range. It has decreased from 74.15 (Mar 23) to 56.81, marking a decrease of 17.34.
- For Price / BV (X), as of Mar 24, the value is 2.61. This value is within the healthy range. It has increased from 2.15 (Mar 23) to 2.61, marking an increase of 0.46.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.73. This value is within the healthy range. It has increased from 1.20 (Mar 23) to 1.73, marking an increase of 0.53.
- For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 23) to 0.02, marking a decrease of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Jubilant Ingrevia Ltd:
- Net Profit Margin: 4.42%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.29% (Industry Average ROCE: 12.89%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 6.68% (Industry Average ROE: 16.38%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.47
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.65
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 52.7 (Industry average Stock P/E: 34.1)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.26
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.42%
About the Company - Qualitative Analysis
No data availabale for About the Company
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Industry not found | Address not found | Contact not found |
Management Data not Available
FAQ
What is the latest intrinsic value of Jubilant Ingrevia Ltd?
The latest intrinsic value of Jubilant Ingrevia Ltd as on 13 March 2025 is 520.91, which is 23.62% lower than the current market price of ₹682.00, indicating the stock is overvalued by 23.62%. The intrinsic value of Jubilant Ingrevia Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹10,865 Cr. and recorded a high/low of ₹885/423 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹2,800 Cr and total liabilities of ₹4,841 Cr.
What is the Market Cap of Jubilant Ingrevia Ltd?
The Market Cap of Jubilant Ingrevia Ltd is 10,865 Cr..
What is the current Stock Price of Jubilant Ingrevia Ltd as on 13 March 2025?
The current stock price of Jubilant Ingrevia Ltd as on 13 March 2025 is ₹682.
What is the High / Low of Jubilant Ingrevia Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of Jubilant Ingrevia Ltd stocks is ₹885/423.
What is the Stock P/E of Jubilant Ingrevia Ltd?
The Stock P/E of Jubilant Ingrevia Ltd is 52.7.
What is the Book Value of Jubilant Ingrevia Ltd?
The Book Value of Jubilant Ingrevia Ltd is 177.
What is the Dividend Yield of Jubilant Ingrevia Ltd?
The Dividend Yield of Jubilant Ingrevia Ltd is 0.73 %.
What is the ROCE of Jubilant Ingrevia Ltd?
The ROCE of Jubilant Ingrevia Ltd is 9.97 %.
What is the ROE of Jubilant Ingrevia Ltd?
The ROE of Jubilant Ingrevia Ltd is 6.93 %.
What is the Face Value of Jubilant Ingrevia Ltd?
The Face Value of Jubilant Ingrevia Ltd is 1.00.